acid sphingomyelinase deficiency

Drug Name: Xenpozyme Active Ingredient: Olipudase alfa Indications: To treat Acid Sphingomyelinase Deficiency (ASD) Approval Date: 8/31/2022 Company: Genzyme Corporation Learn more:  https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/761261s000lbl.pdf